Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 124

1.

Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition.

Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, Colagiuri S, Guariguata L, Motala AA, Ogurtsova K, Shaw JE, Bright D, Williams R; IDF Diabetes Atlas Committee.

Diabetes Res Clin Pract. 2019 Nov;157:107843. doi: 10.1016/j.diabres.2019.107843. Epub 2019 Sep 10.

PMID:
31518657
2.

Detecting the hidden burden of pre-diabetes and diabetes in Western Sydney.

Meyerowitz-Katz G, Seelan S, Gaur P, Francisco R, Ferdousi S, Astell-Burt T, Feng X, Colagiuri S, Maberly G, Hng TM.

Diabetes Res Clin Pract. 2019 May;151:247-251. doi: 10.1016/j.diabres.2019.04.019. Epub 2019 Apr 18.

PMID:
31004674
3.

DTEXT - text messaging intervention to improve outcomes of people with type 2 diabetes: protocol for randomised controlled trial and cost-effectiveness analysis.

Waller K, Furber S, Bauman A, Allman-Farinelli M, van den Dolder P, Hayes A, Facci F, Franco L, Webb A, Moses R, Colagiuri S.

BMC Public Health. 2019 Mar 4;19(1):262. doi: 10.1186/s12889-019-6550-6.

4.

Using the transtheoretical model's stages of change to predict medication adherence in patients with type 2 diabetes mellitus in a primary health care setting.

Arafat Y, Mohamed Ibrahim MI, Awaisu A, Colagiuri S, Owusu Y, Morisky DE, AlHafiz M, Yousif A.

Daru. 2019 Jun;27(1):91-99. doi: 10.1007/s40199-019-00246-7. Epub 2019 Feb 7.

5.

It Is Time to Make Policy for Healthier Food Environments in Australian Universities.

Shi Y, Wang Q, Norman C, Allman-Farinelli M, Colagiuri S.

Nutrients. 2018 Dec 4;10(12). pii: E1909. doi: 10.3390/nu10121909.

6.

The Population Cost-Effectiveness of Weight Watchers with General Practitioner Referral Compared with Standard Care.

Lymer S, Schofield D, Cunich M, Lee CMY, Fuller N, Caterson I, Colagiuri S.

Obesity (Silver Spring). 2018 Aug;26(8):1261-1269. doi: 10.1002/oby.22216.

7.

The cost of diabetes and obesity in Australia.

Lee CMY, Goode B, Nørtoft E, Shaw JE, Magliano DJ, Colagiuri S.

J Med Econ. 2018 Oct;21(10):1001-1005. doi: 10.1080/13696998.2018.1497641. Epub 2018 Jul 19.

PMID:
29978743
8.

The place of gliclazide MR in the evolving type 2 diabetes landscape: A comparison with other sulfonylureas and newer oral antihyperglycemic agents.

Colagiuri S, Matthews D, Leiter LA, Chan SP, Sesti G, Marre M.

Diabetes Res Clin Pract. 2018 Sep;143:1-14. doi: 10.1016/j.diabres.2018.05.028. Epub 2018 May 24. Review.

PMID:
29802958
9.

Public support for government regulatory interventions for overweight and obesity in Australia.

Sainsbury E, Hendy C, Magnusson R, Colagiuri S.

BMC Public Health. 2018 Apr 18;18(1):513. doi: 10.1186/s12889-018-5455-0.

10.

Effect of dietary carbohydrate restriction on glycemic control in adults with diabetes: A systematic review and meta-analysis.

Sainsbury E, Kizirian NV, Partridge SR, Gill T, Colagiuri S, Gibson AA.

Diabetes Res Clin Pract. 2018 May;139:239-252. doi: 10.1016/j.diabres.2018.02.026. Epub 2018 Mar 6. Review.

PMID:
29522789
11.

Haemoglobin glycation index and risk for diabetes-related complications in the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial.

van Steen SC, Woodward M, Chalmers J, Li Q, Marre M, Cooper ME, Hamet P, Mancia G, Colagiuri S, Williams B, Grobbee DE, DeVries JH; ADVANCE Collaborative Group.

Diabetologia. 2018 Apr;61(4):780-789. doi: 10.1007/s00125-017-4539-1. Epub 2018 Jan 8.

12.

Screening for diabetes prevention with diabetes risk scores - A balancing act.

Lee CMY, Versace VL, Malo JA, Shaw JE, Dunbar JA, Colagiuri S.

Diabetes Res Clin Pract. 2018 Jan;135:120-127. doi: 10.1016/j.diabres.2017.11.009. Epub 2017 Nov 15.

PMID:
29155122
13.

Changes in Albuminuria and the Risk of Major Clinical Outcomes in Diabetes: Results From ADVANCE-ON.

Jun M, Ohkuma T, Zoungas S, Colagiuri S, Mancia G, Marre M, Matthews D, Poulter N, Williams B, Rodgers A, Perkovic V, Chalmers J, Woodward M; ADVANCE Collaborative Group.

Diabetes Care. 2018 Jan;41(1):163-170. doi: 10.2337/dc17-1467. Epub 2017 Oct 27.

PMID:
29079715
14.

Primary analysis of the Mandarin-speaking sub-study within the Sydney diabetes prevention program.

Taing CY, Gibson AA, Colagiuri S, Vita P, Cardona-Morrell M, Bauman A, Moore M, Williams M, Milat A, Hony J, Lin S, Gwizd M, Fiatarone Singh MA.

Diabetes Res Clin Pract. 2017 Oct;132:118-126. doi: 10.1016/j.diabres.2017.07.032. Epub 2017 Aug 7.

PMID:
28834772
15.

Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes.

Mohammedi K, Woodward M, Marre M, Colagiuri S, Cooper M, Harrap S, Mancia G, Poulter N, Williams B, Zoungas S, Chalmers J.

Cardiovasc Diabetol. 2017 Jul 27;16(1):95. doi: 10.1186/s12933-017-0574-y.

16.

Prognostic Value of Variability in Systolic Blood Pressure Related to Vascular Events and Premature Death in Type 2 Diabetes Mellitus: The ADVANCE-ON Study.

Ohkuma T, Woodward M, Jun M, Muntner P, Hata J, Colagiuri S, Harrap S, Mancia G, Poulter N, Williams B, Rothwell P, Chalmers J; ADVANCE Collaborative Group.

Hypertension. 2017 Aug;70(2):461-468. doi: 10.1161/HYPERTENSIONAHA.117.09359. Epub 2017 Jun 5.

PMID:
28584014
17.

Reducing cardiovascular disease risk in diabetes: a randomised controlled trial of a quality improvement initiative.

Chalasani S, Peiris DP, Usherwood T, Redfern J, Neal BC, Sullivan DR, Colagiuri S, Zwar NA, Li Q, Patel A.

Med J Aust. 2017 Jun 5;206(10):436-441.

18.

An audit of food and beverage advertising on the Sydney metropolitan train network: regulation and policy implications.

Sainsbury E, Colagiuri S, Magnusson R.

BMC Public Health. 2017 May 22;17(1):490. doi: 10.1186/s12889-017-4433-2.

19.

Behavioural innovation is key to improving the health of one million Australians living with type 2 diabetes.

Zimmet PZ, Moylan J, Colagiuri S.

Med J Aust. 2017 Feb 20;206(3):141-142. No abstract available.

PMID:
28208050
20.

The obesity epidemic and sugar-sweetened beverages: a taxing time.

Colagiuri S.

Med J Aust. 2017 Feb 20;206(3):109-110. No abstract available.

PMID:
28208034

Supplemental Content

Loading ...
Support Center